The Reverse Stock Split will take legal effect at 12:01 A.M. Eastern Time on February 26, 2025, and the Company's Common Stock will open for trading on the NYSE American on February 26, 2025, on a ...
Karyopharm (KPTI) will implement a 1-for-15 reverse stock split of the issued shares of the company’s common stock effective at 5:00 p.m.
In a challenging year for Aclarion, the medical technology company's stock has plummeted to a 52-week low, trading at $4.41. According to InvestingPro data, the company maintains a healthy liquidity ...
BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ:ACON, ACONW), a healthcare technology company, announced today it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent ...
SHOEMAKERSVILLE, Pa., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (Nasdaq: HYFM) ("Hydrofarm” or the "Company”) today announced that its Board of Directors has approved a 1-for-10 ...
The reverse stock split will become effective at 5:00 p.m. Eastern Time on February 7, 2025, with the company’s common stock expected to begin trading on a split-adjusted basis at the opening of ...
In a bid to maintain compliance with Nasdaq's listing standards, Aclarion executed a reverse stock split at a ratio of 1-for-335. This move resulted in the company's gross proceeds reaching ...
Aclarion secured $20 million in funding for its clinical trial of Nociscan. Nociscan is a diagnostic tool that aims to improve surgical outcomes for chronic low back pain patients. Get two weeks ...
The reverse stock splits will not result in a taxable transaction for holders of the Funds, however, the exchange of fractional shares for cash may cause some shareholders to realize gains or ...